2 cheap FTSE 100 shares! Should I buy them today?

FTSE 100 shares are at their lowest valuations for years. Here are a couple that I’ve been thinking about investing in for bumper returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in British companies, and particularly those on the FTSE 100, look very cheap right now. This means I could see better-than-average returns on my investments. That is, of course, providing valuations return to normal levels. Here’s what I mean.

A great time to buy British shares?

The FTSE 100 forward price-to-earnings ratio stands at just under 11 right now. That’s cheap compared to the 10-year average of 22. For the same earnings, it’s like I’m getting shares for half price. 

The UK is looking cheap compared to prominent international indexes as the US S&P 500 has a P/E ratio of roughly 18 and the MSCI World Index stands at around 15. 

The Financial Times went so far as to say, “it is embarrassing that the value of UK equities has fallen so far behind that of international peers.”

In other words, the earnings that FTSE 100 companies are posting aren’t reflected in their share prices.

So what does this mean for me? Well, if I bought shares in the right FTSE 100 companies today, I could enjoy superb returns for my portfolio. Here are two I’m looking at. 

Pharma giant

One stock that’s caught my eye is GSK (LSE: GSK). The pharmaceutical firm formerly known as GlaxoSmithKline trades at a forward P/E ratio of just 10, and its share price has dipped to levels no higher than they were in 1997.

Why is the share price so low? Well, last year GSK went through a rough period. It started with the spin-off of its consumer healthcare division, a listed company now known as Haleon. And it continued with a lawsuit involving its former Zantac heartburn medication, and also an announcement of a reduced dividend. 

Despite the problems, with increased revenue year on year for the better part of a decade, and 60 new drugs in the pipeline, the GSK share price definitely looks to be on the cheaper side. I think I’ll buy some of its shares soon. 

Cigarettes on sale?

Cigarette maker British American Tobacco (LSE:BATS) is another business on my watchlist. The company trades at a forward P/E ratio of 8.1 and the share price is down 43% from all-time highs.

This looks cheap by itself, but also looks like a bargain to me when I factor in that BAT offers shareholders a 7.6% annual yield. That’s one of the highest dividends on the FTSE 100 and would offer me automatic cash payments just for holding the stock. 

On the other hand, one of the reasons for such high dividends is the cigarette industry’s ‘sin stock’ status. A lot of investors are put off on ethical grounds – breaking ESG standards, as some would call it.

Other investors also likely recognise the risk in holding shares in a company that produces products that might, in the long run, prove unpopular or even be illegal.

In the short term, this stock looks attractive. There are actually more smokers worldwide than ever, and BAT, with its product line of cigarette brands like Dunhill and Lucky Strike, is a truly global business. The long-term outlook for cigarettes does mean this won’t be a buy for me, however.

John Fieldsend has no position in any of the shares mentioned. The Motley Fool UK has recommended British American Tobacco P.l.c. and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Female student sitting at the steps and using laptop
Investing Articles

UK stocks: the contrarian choice for 2026

UK stocks aren’t the consensus choice for investors at the moment. But some smart money managers who are looking to…

Read more »

Investing Articles

Down 20% in 2025, shares in this under-the-radar UK defence tech firm could be set for a strong 2026

Cohort shares are down 20% this year, but NATO spending increases could offer UK investors a huge potential opportunity going…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

New to investing? Here’s Warren Buffett’s strategy for starting from scratch

Warren Buffett says he could find opportunities to earn a 50% annual return in the stock market if he was…

Read more »

Investing Articles

Can the sensational Barclays share price do it all over again in 2026?

Harvey Jones is blown away by what the Barclays share price has been doing lately. Now he looks at whether…

Read more »

Investing Articles

Prediction: in 2026 mega-cheap Diageo shares could turn £10,000 into…

Diageo shares have been burning wealth lately but Harvey Jones says long-suffering investors in the FTSE 100 stock may get…

Read more »

Investing Articles

This overlooked FTSE 100 share massively outperformed Tesla over 5 years!

Tesla has been a great long-term investment, but this lesser-known FTSE 100 company would have been an even better one.

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

I’m backing these 3 value stocks to the hilt – will they rocket in 2026?

Harvey Jones has bought these three FTSE 100 value stocks on three occasions lately, averaging down every time they fall.…

Read more »

Investing Articles

Can the barnstorming Tesco share price do it all over again in 2026?

Harvey Jones is blown away by just how well the Tesco share price has done lately, and asks whether the…

Read more »